ID: ALA3350566

Max Phase: Preclinical

Molecular Formula: C28H22N2O9

Molecular Weight: 530.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CO[C@H]1[C@H](OC=O)[C@@H](O)[C@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)OC4=O)O[C@@H]1CO

Standard InChI:  InChI=1S/C28H22N2O9/c1-36-24-16(10-31)38-26(23(33)25(24)37-11-32)30-15-9-5-3-7-13(15)18-20-19(27(34)39-28(20)35)17-12-6-2-4-8-14(12)29-21(17)22(18)30/h2-9,11,16,23-26,29,31,33H,10H2,1H3/t16-,23-,24-,25-,26-/m1/s1

Standard InChI Key:  QFFFJGCDBNZSHF-CNFVFWEUSA-N

Associated Targets(Human)

CEM-SS (2428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus cereus (7522 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptomyces chartreusis (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 530.49Molecular Weight (Monoisotopic): 530.1325AlogP: 2.55#Rotatable Bonds: 5
Polar Surface Area: 149.31Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.31CX Basic pKa: CX LogP: 2.50CX LogD: 2.50
Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.18Np Likeness Score: 1.18

References

1. Moreau P, Anizon F, Sancelme M, Prudhomme M, Bailly C, Carrasco C, Ollier M, Sevère D, Riou JF, Fabbro D, Meyer T, Aubertin AM..  (1998)  Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.,  41  (10): [PMID:9572888] [10.1021/jm970843+]

Source